Intrommune Therapeutics
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
20 W 125th St Apt 1, New York, New York,...Phone Number
(646) 494-8432Website
www.intrommune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Intrommune Therapeutics
Intrommune Therapeutics is dedicated to developing innovative treatments for food allergies, focusing on a novel drug delivery platform that incorporates therapeutic agents into functional toothpaste. This approach aims to simplify the management of food allergies by allowing patients to administer treatment conveniently while brushing their teeth. With over 33 million Americans affected by food allergies, the company seeks to provide a safe and effective long-term solution through its oral mucosal immunotherapy (OMIT) platform. Their target clients include individuals suffering from food allergies who are looking for easier and more effective management options.Explore more
Intrommune Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Intrommune Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Intrommune Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Intrommune Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Intrommune Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Intrommune Therapeutics is spiking on competitors!
Product Launch: Get notified when Intrommune Therapeutics launches new products
Funding: Get notified immidiatlly once Intrommune Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Intrommune Therapeutics
Intrommune Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Intrommune Therapeutics
Compare insights from companies similar to Intrommune Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Intrommune Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Intrommune Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Intrommune Therapeutics.
Intrommune Therapeutics Tech Stack
A closer look at the technologies used by Intrommune Therapeutics
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Executive Move
Board of Directors
Executive Move
Board of Directors
New Hire
Executive Move
Promotion
Executive Move
Intrommune Therapeutics News & Media
Intrommune Therapeutics Announces Independent Editorial Highlighting Breakthrough Safety Data for Novel Toothpaste Peanut Allergy Treatment
Intrommune welcomes an independent editorial that was recently published in Annals of Allergy, Asthma & Immunology.Intrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & Immunology
Groundbreaking Study Demonstrates Safety and Tolerability of Oral Mucosal Immunotherapy (OMIT) for Peanut Allergy Using ToothpasteIntrommune Therapeutics Presents Oral Mucosal Immunotherapy Updates at Leading Industry Events
Intrommune Therapeutics Presents Oral Mucosal Immunotherapy Updates at Leading Industry EventsIntrommune Therapeutics Strengthens Board of Directors with Appointments of Dr ... - BioSpace
Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya - read this article along with other careers information, tips and advice on BioSpace
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Intrommune Therapeutics
Sign Up For FreeTo access detailed company insights
Intrommune Therapeutics is dedicated to developing innovative treatments for food allergies, focusing on a novel drug delivery platform that incorporates therapeutic agents into functional toothpaste. This approach aims to simplify the management of food allergies by allowing patients to administer treatment conveniently while brushing their teeth.... Read More
